首页> 外国专利> PHARMACEUTICAL COMPOSITION FOR TREATING ENCEPHALOMA OR PHARMACEUTICAL COMPOSITION FOR REDUCING TEMOZOLOMIDE RESISTANCE OF ENCEPHALOMA CELL, AND USE THEREOF

PHARMACEUTICAL COMPOSITION FOR TREATING ENCEPHALOMA OR PHARMACEUTICAL COMPOSITION FOR REDUCING TEMOZOLOMIDE RESISTANCE OF ENCEPHALOMA CELL, AND USE THEREOF

机译:用于治疗脑病的药物组合物或用于减少脑病细胞的替莫唑胺耐药性的药物组合物及其用途

摘要

PROBLEM TO BE SOLVED: To provide a pharmaceutical composition for treating encephaloma, or a pharmaceutical composition for reducing temozolomide resistance of encephaloma cell.SOLUTION: The pharmaceutical composition for treating encephaloma, or the pharmaceutical composition for reducing the temozolomide resistance of encephaloma cell, comprises a pharmaceutically acceptable carrier, and an effective amount of an active ingredient selected from the group consisting of (Z)-butylidene phthalide of chemical formula (I), a pharmaceutically acceptable salt of (Z)-butylidene phthalide, a pharmaceutically acceptable ester of (Z)-butylidene phthalide, and their combinations.
机译:解决的问题:提供一种治疗脑瘤的药物组合物或降低脑瘤细胞的替莫唑胺耐药性的药物组合物。药学上可接受的载体,和有效量的选自化学式(I)的(Z)-亚丁基邻苯二甲酸酯,(Z)-亚丁基邻苯二甲酸酯的药学上可接受的盐,(Z)的药学上可接受的酯的活性成分)-亚丁基苯酞及其组合。

著录项

  • 公开/公告号JP2012144512A

    专利类型

  • 公开/公告日2012-08-02

    原文格式PDF

  • 申请/专利权人 CHINA MEDICAL UNIV;

    申请/专利号JP20110144450

  • 申请日2011-06-29

  • 分类号A61K31/365;A61P35;A61P43;A61K31/4188;C07D307/88;C07D487/04;

  • 国家 JP

  • 入库时间 2022-08-21 17:43:50

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号